Ann Rheum Dis. 2002 Nov;61 Suppl 2:ii64-6.

Using estimated yearly progression rates to compare radiographic data across recent randomised controlled trials in rheumatoid arthritis.

Strand V, Landéwé R, van der Heijde D.

Source

Stanford University, Division of Immunology, Palo Alto, CA, USA. vstrand@aol.com

PMID:: 12379626; [PubMed - indexed for MEDLINE]
PMCID:: PMC1766712

Free PMC Article

Images from this publication.See all images (2)Free text

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

Antirheumatic Agents

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

Supplemental Content

Save items

Related citations in PubMed

Review Evidence from clinical trials and long-term observational studies that disease-modifying anti-rheumatic drugs slow radiographic progression in rheumatoid arthritis: updating a 1983 review. [Rheumatology (Oxford). 2002]
Review Evidence from clinical trials and long-term observational studies that disease-modifying anti-rheumatic drugs slow radiographic progression in rheumatoid arthritis: updating a 1983 review.
Pincus T, Ferraccioli G, Sokka T, Larsen A, Rau R, Kushner I, Wolfe F. Rheumatology (Oxford). 2002 Dec; 41(12):1346-56.
Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate. [Ann Rheum Dis. 2009]
Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate.
Wells G, Becker JC, Teng J, Dougados M, Schiff M, Smolen J, Aletaha D, van Riel PL. Ann Rheum Dis. 2009 Jun; 68(6):954-60. Epub 2008 May 19.
Review Interpreting radiographic data in rheumatoid arthritis. [Ann Rheum Dis. 2003]
Review Interpreting radiographic data in rheumatoid arthritis.
Ory PA. Ann Rheum Dis. 2003 Jul; 62(7):597-604.
Review Is radiographic progression a realistic outcome measure in clinical trials with early inflammatory arthritis? [Clin Exp Rheumatol. 2003]
Review Is radiographic progression a realistic outcome measure in clinical trials with early inflammatory arthritis?
Landewé R, van de Heijde D. Clin Exp Rheumatol. 2003 Sep-Oct; 21(5 Suppl 31):S37-41.
Review Radiographic data from recent randomized controlled trials in rheumatoid arthritis: what have we learned? [Arthritis Rheum. 2003]
Review Radiographic data from recent randomized controlled trials in rheumatoid arthritis: what have we learned?
Strand V, Sharp JT. Arthritis Rheum. 2003 Jan; 48(1):21-34.

See reviews... See all...

Cited by 3 PubMed Central articles

Clinical, radiographic and functional effectiveness of tocilizumab for rheumatoid arthritis patients--REACTION 52-week study. [Rheumatology (Oxford). 2011]
Clinical, radiographic and functional effectiveness of tocilizumab for rheumatoid arthritis patients--REACTION 52-week study.
Takeuchi T, Tanaka Y, Amano K, Hoshi D, Nawata M, Nagasawa H, Sato E, Saito K, Kaneko Y, Fukuyo S, et al. Rheumatology (Oxford). 2011 Oct; 50(10):1908-15. Epub 2011 Jul 13.
Abatacept inhibits progression of structural damage in rheumatoid arthritis: results from the long-term extension of the AIM trial. [Ann Rheum Dis. 2008]
Abatacept inhibits progression of structural damage in rheumatoid arthritis: results from the long-term extension of the AIM trial.
Genant HK, Peterfy CG, Westhovens R, Becker JC, Aranda R, Vratsanos G, Teng J, Kremer JM. Ann Rheum Dis. 2008 Aug; 67(8):1084-9. Epub 2007 Dec 17.
Radiography as primary outcome in rheumatoid arthritis: acceptable sample sizes for trials with 3 months' follow up. [Ann Rheum Dis. 2004]
Radiography as primary outcome in rheumatoid arthritis: acceptable sample sizes for trials with 3 months' follow up.
Bruynesteyn K, Landewé R, van der Linden S, van der Heijde D. Ann Rheum Dis. 2004 Nov; 63(11):1413-8. Epub 2004 Mar 22.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Using estimated yearly progression rates to compare radiographic data across rec...
Using estimated yearly progression rates to compare radiographic data across recent randomised controlled trials in rheumatoid arthritis.
Ann Rheum Dis. 2002 Nov ;61 Suppl 2:ii64-6.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: